Enveric Biosciences Inc
Sector: Manufacturing
Industry: Pharmaceutical Products
1.17
-0.06
(-4.88%)
Volume:
37,995
52 week range:
1.01 - 15.45
Market Cap:
2.892M
Company Description:
Enveric Biosciences, Inc. engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 for the. treatment of cancer related distress. EV102, a cannabinoid cream for topical skin application; and EV101, a. cannabinoid and chemotherapy combination therapy.